Immunohistochemical Expression of B-Cell Lymphoma-2 Gene with Clinicopathological Correlation: A Comparative Analysis of Triple Negative and Non-Triple Negative Breast Cancers
Background: B-Cell Lymphoma-2 gene is an anti-apoptotic protein associated with favorable prognosis in patients with breast cancer. The present study focused on immunohistochemical expression of the aforementioned gene with clinicopathological correlation in non-triple negative breast cancers (NTNBC...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kaviani Breast Disease Institute
2017-06-01
|
| Series: | Archives of Breast Cancer |
| Subjects: | |
| Online Access: | https://archbreastcancer.com/index.php/abc/article/view/130 |
| _version_ | 1818207388598009856 |
|---|---|
| author | Muhammad Zubair Iqbal Muhammad Hassan Tariq Rabia Ahmad Akhter Ali Salma Gul |
| author_facet | Muhammad Zubair Iqbal Muhammad Hassan Tariq Rabia Ahmad Akhter Ali Salma Gul |
| author_sort | Muhammad Zubair |
| collection | DOAJ |
| description | Background: B-Cell Lymphoma-2 gene is an anti-apoptotic protein associated with favorable prognosis in patients with breast cancer. The present study focused on immunohistochemical expression of the aforementioned gene with clinicopathological correlation in non-triple negative breast cancers (NTNBCs) and triple negative breast cancers (TNBCs).
Methods: We investigated 258 cases of primary breast cancers; they were divided into 2 groups (NTNBCs and TNBCs) based on their expression of estrogen receptor (ER), progesterone receptors (PR), and Her-2/neu receptors. BCL-2 expression was correlated with age, tumor size, tumor grade, histological subtype, lymph node status, and lymphovascular invasion (LVI).
Results: Among NTNBCs, 68.2% of cases expressed BCL-2 as compared to 53.3% in TNBCs (P-value = 0.035). In both groups, BCL-2 expression was significantly higher in younger patients, without lymphovascular invasion and lower grade (borderline significant in TNBCs). The variable which was associated with higher BCL-2 expression only in NTNBCs was smaller tumor size. In contrast, in TNBCs invasive ductal carcinoma was significantly associated with BCL-2 expression.
Conclusions: BCL-2 showed association with various clinicohistopathological characteristics in TNBC and NTNBC breast cancer patients. Yet, some of these variables were potentially related to better prognosis (the lack of LVI, smaller tumor size, and lower grade). On the other hand, younger age, which is a feature generally associated with poorer prognosis, was significantly related to BCL-2 expression. |
| first_indexed | 2024-12-12T04:28:08Z |
| format | Article |
| id | doaj.art-6378e58283c84abc8b44a985da84378a |
| institution | Directory Open Access Journal |
| issn | 2383-0433 |
| language | English |
| last_indexed | 2024-12-12T04:28:08Z |
| publishDate | 2017-06-01 |
| publisher | Kaviani Breast Disease Institute |
| record_format | Article |
| series | Archives of Breast Cancer |
| spelling | doaj.art-6378e58283c84abc8b44a985da84378a2022-12-22T00:38:10ZengKaviani Breast Disease InstituteArchives of Breast Cancer2383-04332017-06-014210.19187/abc.20174258-63114Immunohistochemical Expression of B-Cell Lymphoma-2 Gene with Clinicopathological Correlation: A Comparative Analysis of Triple Negative and Non-Triple Negative Breast CancersMuhammad Zubair0Iqbal Muhammad1Hassan Tariq2Rabia Ahmad3Akhter Ali4Salma Gul5Consultant Histopathologist, Histopathology department, Armed Forces Institute of Pathology, Rawalpindi, PakistanConsultant Histopathologist, Histopathology department, Armed Forces Institute of Pathology, Rawalpindi, PakistanResident of Histopathology, Histopathology department, Armed Forces Institute of Pathology, Rawalpindi, PakistanConsultant Histopathologist, Histopathology department, Armed Forces Institute of Pathology, Rawalpindi, PakistanResident of Histopathology, Histopathology department, Armed Forces Institute of Pathology, Rawalpindi, PakistanDepartment of Pathology, Khyber Medical University, Peshawar, PakistanBackground: B-Cell Lymphoma-2 gene is an anti-apoptotic protein associated with favorable prognosis in patients with breast cancer. The present study focused on immunohistochemical expression of the aforementioned gene with clinicopathological correlation in non-triple negative breast cancers (NTNBCs) and triple negative breast cancers (TNBCs). Methods: We investigated 258 cases of primary breast cancers; they were divided into 2 groups (NTNBCs and TNBCs) based on their expression of estrogen receptor (ER), progesterone receptors (PR), and Her-2/neu receptors. BCL-2 expression was correlated with age, tumor size, tumor grade, histological subtype, lymph node status, and lymphovascular invasion (LVI). Results: Among NTNBCs, 68.2% of cases expressed BCL-2 as compared to 53.3% in TNBCs (P-value = 0.035). In both groups, BCL-2 expression was significantly higher in younger patients, without lymphovascular invasion and lower grade (borderline significant in TNBCs). The variable which was associated with higher BCL-2 expression only in NTNBCs was smaller tumor size. In contrast, in TNBCs invasive ductal carcinoma was significantly associated with BCL-2 expression. Conclusions: BCL-2 showed association with various clinicohistopathological characteristics in TNBC and NTNBC breast cancer patients. Yet, some of these variables were potentially related to better prognosis (the lack of LVI, smaller tumor size, and lower grade). On the other hand, younger age, which is a feature generally associated with poorer prognosis, was significantly related to BCL-2 expression.https://archbreastcancer.com/index.php/abc/article/view/130B-Cell Lymphoma-2 (BCL-2)Non-Triple Negative Breast Cancers (NTNBcs)Triple Negative Breast Cancers (TNBCs)Immunohistochemistry (IHC) |
| spellingShingle | Muhammad Zubair Iqbal Muhammad Hassan Tariq Rabia Ahmad Akhter Ali Salma Gul Immunohistochemical Expression of B-Cell Lymphoma-2 Gene with Clinicopathological Correlation: A Comparative Analysis of Triple Negative and Non-Triple Negative Breast Cancers Archives of Breast Cancer B-Cell Lymphoma-2 (BCL-2) Non-Triple Negative Breast Cancers (NTNBcs) Triple Negative Breast Cancers (TNBCs) Immunohistochemistry (IHC) |
| title | Immunohistochemical Expression of B-Cell Lymphoma-2 Gene with Clinicopathological Correlation: A Comparative Analysis of Triple Negative and Non-Triple Negative Breast Cancers |
| title_full | Immunohistochemical Expression of B-Cell Lymphoma-2 Gene with Clinicopathological Correlation: A Comparative Analysis of Triple Negative and Non-Triple Negative Breast Cancers |
| title_fullStr | Immunohistochemical Expression of B-Cell Lymphoma-2 Gene with Clinicopathological Correlation: A Comparative Analysis of Triple Negative and Non-Triple Negative Breast Cancers |
| title_full_unstemmed | Immunohistochemical Expression of B-Cell Lymphoma-2 Gene with Clinicopathological Correlation: A Comparative Analysis of Triple Negative and Non-Triple Negative Breast Cancers |
| title_short | Immunohistochemical Expression of B-Cell Lymphoma-2 Gene with Clinicopathological Correlation: A Comparative Analysis of Triple Negative and Non-Triple Negative Breast Cancers |
| title_sort | immunohistochemical expression of b cell lymphoma 2 gene with clinicopathological correlation a comparative analysis of triple negative and non triple negative breast cancers |
| topic | B-Cell Lymphoma-2 (BCL-2) Non-Triple Negative Breast Cancers (NTNBcs) Triple Negative Breast Cancers (TNBCs) Immunohistochemistry (IHC) |
| url | https://archbreastcancer.com/index.php/abc/article/view/130 |
| work_keys_str_mv | AT muhammadzubair immunohistochemicalexpressionofbcelllymphoma2genewithclinicopathologicalcorrelationacomparativeanalysisoftriplenegativeandnontriplenegativebreastcancers AT iqbalmuhammad immunohistochemicalexpressionofbcelllymphoma2genewithclinicopathologicalcorrelationacomparativeanalysisoftriplenegativeandnontriplenegativebreastcancers AT hassantariq immunohistochemicalexpressionofbcelllymphoma2genewithclinicopathologicalcorrelationacomparativeanalysisoftriplenegativeandnontriplenegativebreastcancers AT rabiaahmad immunohistochemicalexpressionofbcelllymphoma2genewithclinicopathologicalcorrelationacomparativeanalysisoftriplenegativeandnontriplenegativebreastcancers AT akhterali immunohistochemicalexpressionofbcelllymphoma2genewithclinicopathologicalcorrelationacomparativeanalysisoftriplenegativeandnontriplenegativebreastcancers AT salmagul immunohistochemicalexpressionofbcelllymphoma2genewithclinicopathologicalcorrelationacomparativeanalysisoftriplenegativeandnontriplenegativebreastcancers |